| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 3.680 | 5.892 | 11.830 | 3.542 | 19.212 |
| Total Income - EUR | - | - | - | 11.156 | 2 | 3.866 | 5.892 | 34.365 | 3.542 | 19.212 |
| Total Expenses - EUR | - | - | - | 11.394 | 5.528 | 6.101 | 7.878 | 7.058 | 21.455 | 20.668 |
| Gross Profit/Loss - EUR | - | - | - | -237 | -5.526 | -2.235 | -1.986 | 27.307 | -17.913 | -1.456 |
| Net Profit/Loss - EUR | - | - | - | -237 | -5.526 | -2.335 | -2.163 | 26.974 | -17.948 | -1.648 |
| Employees | - | - | - | 0 | 1 | 1 | 0 | 0 | 2 | 2 |
Check the financial reports for the company - Nutriterapii Apicole S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 6.793 | 17.138 | 16.958 | 15.954 | 12.850 | 12.183 | 19.177 |
| Current Assets | - | - | - | 12.529 | 2.210 | 2.024 | 2.428 | 5.120 | 5.225 | 1.970 |
| Inventories | - | - | - | 848 | 832 | 1.655 | 1.619 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.054 | 2 | 2 | 0 | 705 | 201 |
| Cash | - | - | - | 11.681 | 324 | 366 | 807 | 5.120 | 4.520 | 1.769 |
| Shareholders Funds | - | - | - | -194 | -5.716 | -7.943 | -9.929 | 17.014 | -986 | -2.629 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.007 | 1.645 | 3.949 | 5.846 | 955 | 4.267 | 9.728 |
| Income in Advance | - | - | - | 23.881 | 23.419 | 22.975 | 22.465 | 0 | 14.127 | 14.048 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nutriterapii Apicole S.r.l.